Ruto announces cancer drug prices slashed by up to 95 per cent after Pfizer deal
President William Ruto has announced what he described as a major breakthrough in Kenya’s fight against cancer after the government signed a landmark agreement with American pharmaceutical giant Pfizer, a deal expected to slash the cost of several life-saving cancer medicines by as much as 95 per cent. Under the agreement between Pfizer and the […]
Kenya has reached an agreement with Pfizer to significantly reduce the cost of cancer drugs, benefiting patients across the nation. President William Ruto disclosed that the deal, under Pfizer’s Accord for a Healthier World programme, will slash the price of treatments for various cancers, including breast, stomach, colon, lung, prostate, oesophageal, leukaemia, lymphoma, and multiple myeloma.
The cost of treatment could drop from as high as Ksh1 million to less than Ksh50,000 per cycle, making the Ksh800,000 cancer treatment package under the Social Health Authority fully adequate for patients. This agreement also expedites access to newer cancer medicines, eliminating the existing 10-year waiting period. Ruto highlighted the partnership's potential to boost local pharmaceutical manufacturing in Africa through technology and medicine access.
Brief written by urgent.news from KBC's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
